Skip to content
ProPublica Donate
ProPublica Donate

Parker Institute For Cancer Immunotherapy

Organization summary

Type of Nonprofit

Designated as a Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Category: Health — General and Rehabilitative / Fund Raising and/or Fund Distribution (NTEE)

Donations to this organization are tax deductible.

Details

According to its Dec. 2023 tax filing, this nonprofit:

Provided first-class or charter travel
Organization provided first-class or charter travel to key employees or officers. Details are reported on Schedule J.
Reported conflict of interest transactions
Organizations must report loans, grants or business transactions with interested parties, which may include key employees and officers, their family members and any businesses in which they hold a controlling interest. These transactions must be reported on Schedule L.

Summary charts: organization finances over time

Revenue
$23.7M (2023)

Expenses
$42.9M (2023)

Total Assets
$255M (2023)

Total Liabilities
$52.8M (2023)

Source: Form 990 tax filings from 2015 to 2023

Tax Filings by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Fiscal Year Ending Dec.
2023

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$23,662,636
Expenses
$42,903,351
Net Income
-$19,240,715
Net Assets
$202,213,973
Notable Sources of Revenue Percent of Total Revenue
Contributions $1,204,708
5.1%
Program Services $8,658,418
36.6%
Investment Income $5,346,695
22.6%
Bond Proceeds $0
Royalties $1,451,074
6.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $7,001,741
29.6%
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $2,248,427
5.2%
Professional Fundraising Fees $0
Other Salaries and Wages $7,587,904
17.7%
Assets/Debt
Total Assets $255,027,743
Total Liabilities $52,813,770
Net Assets $202,213,973
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Ute Dugan Md (Chief Medical Officer) $789,156 $0 $55,067
John Connolly Phd (Chief Scientific Officer) $763,765 $0 $53,749
Tarak Mody (Chief Business Officer) $614,960 $0 $54,899
Kevin Marks (Chief Legal Officer) $559,373 $0 $114,899
Sara Coblin (Sr Vp Finance & Admin.) $548,044 $0 $38,646
Shane Corcoran (Senior Vp, Strat. Ops. & Comms) $547,440 $0 $41,286
Marko Spasic (Sr Medical Dir, Head Of Med) $476,280 $0 $15,180
Chris Cabanski (Sr Dir, Network Clinical Res.) $355,867 $0 $41,334
Sean N Parker (Chair Of The Board & Director) $0 $0 $0
Michael Polansky (Executive Vp & Director) $0 $0 $0
Tom Van Loben Sels (Treasurer & Director) $0 $0 $0
Jeffrey A Bluestone Phd (Vice Chair & Director) $0 $0 $0
Tony Coles Md (Director) $0 $0 $0
Eric Esrailian Md Mph (Director) $0 $0 $0
Scott Gottlieb Md (Director) $0 $0 $0
Ben Horowitz (Director) $0 $0 $0
Jeff Huber (Director) $0 $0 $0
Bob Hugin (Director) $0 $0 $0
Reed Jobs (Director) $0 $0 $0
Joel Marcus (Director Thru 3/23) $0 $0 $0
Bob Nelsen (Director) $0 $0 $0
Bruce Parker Phd (Director) $0 $0 $0
Bob Pittman (Director) $0 $0 $0
Ramy Ibrahim Md (Director) $0 $0 $0
Margo Georgiadis (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2022

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$32,769,137
Expenses
$62,241,652
Net Income
-$29,472,515
Net Assets
$249,519,391
Notable Sources of Revenue Percent of Total Revenue
Contributions $691,633
2.1%
Program Services $13,501,237
41.2%
Investment Income $1,676,519
5.1%
Bond Proceeds $0
Royalties $759,535
2.3%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $14,043,373
42.9%
Net Inventory Sales $0
Other Revenue $2,096,840
6.4%
Notable Expenses Percent of Total Expenses
Executive Compensation $2,237,353
3.6%
Professional Fundraising Fees $0
Other Salaries and Wages $15,406,447
24.8%
Assets/Debt
Total Assets $307,154,607
Total Liabilities $57,635,216
Net Assets $249,519,391
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
John Connolly Phd (Chief Scientific Officer) $854,600 $0 $34,231
Ute Dugan Md (Chief Medical Officer) $751,934 $0 $43,380
Tarak Mody (Chief Business Officer) $586,752 $0 $43,381
Justin Fairchild (Vp Clinical Dev. Thru 9/30/22) $535,136 $0 $33,360
Lisa Butterfield (Vp Res. & Dev. Thru 7/31/22) $525,443 $0 $29,610
Sara Coblin (Sr Vp Finance & Admin.) $522,112 $0 $31,096
Shane Corcoran (Senior Vp, Strat. Ops. & Comms) $521,356 $0 $42,581
Lacey Padron (Vp Informatics) $400,026 $0 $38,873
Sean N Parker (Chair Of The Board & Director) $0 $0 $0
Michael Polansky (Executive Vp & Director) $0 $0 $0
Tom Van Loben Sels (Treasurer & Director) $0 $0 $0
Jeffrey A Bluestone Phd (Vice Chair & Director) $0 $0 $0
Tony Coles Md (Director) $0 $0 $0
Eric Esrailian Md Mph (Director) $0 $0 $0
Scott Gottlieb Md (Director) $0 $0 $0
Ben Horowitz (Director) $0 $0 $0
Jeff Huber (Director) $0 $0 $0
Bob Hugin (Director) $0 $0 $0
Reed Jobs (Director) $0 $0 $0
Joel Marcus (Director) $0 $0 $0
Bob Nelsen (Director) $0 $0 $0
Bruce Parker Phd (Director) $0 $0 $0
Bob Pittman (Director) $0 $0 $0
Ramy Ibrahim Md (Director) $0 $0 $0
Margo Georgiadis (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2021

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$170,996,190
Expenses
$52,643,221
Net Income
$118,352,969
Net Assets
$327,532,401
Notable Sources of Revenue Percent of Total Revenue
Contributions $160,955,548
94.1%
Program Services $9,757,426
5.7%
Investment Income $94,889
0.1%
Bond Proceeds $0
Royalties $188,327
0.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $2,754,056
5.2%
Professional Fundraising Fees $0
Other Salaries and Wages $14,707,068
27.9%
Assets/Debt
Total Assets $380,437,987
Total Liabilities $52,905,586
Net Assets $327,532,401
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Ute Dugan Md (Chief Medical Officer) $750,812 $0 $40,628
John Connolly Phd (Chief Scientific Officer) $727,762 $0 $10,546
Theresa Lavalle (Vp Translational Medicine & Re) $565,786 $0 $44,578
Ramy Ibrahim Md (Director & Former Cmo) $538,067 $0 $1,212
Melinda Griffith (Chief Legal Counsel) $520,279 $0 $22,561
Lisa Butterfield (Vp Research & Development) $428,440 $0 $22,746
Justin Fairchild (Vp Clinical Development) $401,460 $0 $40,628
Frederic Pla Phd (Coo Through 4/15/21) $377,316 $0 $9,009
Marko Spasic (Senior Medical Director) $363,124 $0 $10,787
Sara Coblin (Sr Vp Finance As Of 6/1/21) $284,233 $0 $14,469
Sean N Parker (Chair Of The Board & Director) $0 $0 $0
Michael Polansky (Executive Vp & Director) $0 $0 $0
Tom Van Loben Sels (Treasurer & Director) $0 $0 $0
Jeffrey A Bluestone Phd (Vice Chair & Director) $0 $0 $0
Tony Coles Md (Director) $0 $0 $0
Eric Esrailian Md Mph (Director) $0 $0 $0
Scott Gottlieb Md (Director) $0 $0 $0
Ben Horowitz (Director) $0 $0 $0
Jeff Huber (Director) $0 $0 $0
Bob Hugin (Director) $0 $0 $0
Reed Jobs (Director) $0 $0 $0
Joel Marcus (Director) $0 $0 $0
Bob Nelsen (Director) $0 $0 $0
Bruce Parker Phd (Director) $0 $0 $0
Bob Pittman (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2020

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$66,027,113
Expenses
$69,855,756
Net Income
-$3,828,643
Net Assets
$144,770,423
Notable Sources of Revenue Percent of Total Revenue
Contributions $54,173,409
82.0%
Program Services $10,178,848
15.4%
Investment Income $261,746
0.4%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$147,500
Net Inventory Sales $0
Other Revenue $1,560,610
2.4%
Notable Expenses Percent of Total Expenses
Executive Compensation $2,212,224
3.2%
Professional Fundraising Fees $51,000
0.1%
Other Salaries and Wages $13,965,153
20.0%
Assets/Debt
Total Assets $152,630,223
Total Liabilities $7,859,800
Net Assets $144,770,423
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Ramy Ibrahim Md (Chief Medical Officer) $838,744 $0 $35,362
Frederic Pla Phd (Chief Operating Officer) $521,498 $0 $12,323
Theresa Lavallee Phd (Vp Translational Medicine) $453,830 $0 $35,417
Nikesh Kotecha Phd (Vp Informatics) $433,823 $0 $15,582
Susan Schultz Thru 9120 (Vp Business Operations) $425,613 $0 $26,154
Melinda Griffith (Chief Legal Counsel) $422,891 $0 $17,827
Cheryl Selinsky Phd (Vp Research Operations) $393,328 $0 $17,797
Lisa Butterfield (Vice President, Research And Development) $383,865 $0 $20,367
John Connolly Phd (Chief Scientific Officer) $349,964 $0 $2,567
Sean N Parker (Chair Of The Board & Director) $0 $0 $0
Michael Polansky (Executive Vp & Director) $0 $0 $0
Tom Van Loben Sels (Treasurer & Director) $0 $0 $0
Jeffrey A Bluestone Phd (Vice Chair & Director) $0 $0 $0
Tony Coles Md (Director) $0 $0 $0
Eric Esrailian Md Mph (Director) $0 $0 $0
Scott Gottlieb Md (Director) $0 $0 $0
Ben Horowitz (Director) $0 $0 $0
Jeff Huber (Director) $0 $0 $0
Bob Hugin (Director) $0 $0 $0
Reed Jobs (Director) $0 $0 $0
Joel Marcus (Director) $0 $0 $0
Bob Nelsen (Director) $0 $0 $0
Bruce Parker Phd (Director) $0 $0 $0
Bob Pittman (Director) $0 $0 $0
Susan Dawson (Secretary) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2019

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$162,648,564
Expenses
$77,964,615
Net Income
$84,683,949
Net Assets
$148,599,066
Notable Sources of Revenue Percent of Total Revenue
Contributions $146,644,584
90.2%
Program Services $15,232,654
9.4%
Investment Income $771,326
0.5%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $2,052,973
2.6%
Professional Fundraising Fees $200,000
0.3%
Other Salaries and Wages $13,105,701
16.8%
Assets/Debt
Total Assets $159,252,481
Total Liabilities $10,653,415
Net Assets $148,599,066
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Ramy Ibrahim (Chief Medical Officer) $884,132 $0 $25,988
Jeffrey A Bluestone Phd (President/Ceo & Director) $709,428 $0 $23,895
Frederick J Ramsdell (Chief Scientific Officer (Thru 12/19)) $432,060 $0 $26,223
Nikesh Kotecha (Vp Informatics) $417,850 $0 $20,797
Theresa Lavallee (Vp Translational Medicine) $416,755 $0 $34,480
Melinda Griffith (Chief Legal Counsel, Vp St) $409,259 $0 $20,452
Cheryl Selinsky Phd (Vp Research Operations) $379,251 $0 $13,254
Susan Schultz (Vp Business Operations) $377,457 $0 $32,074
Sean N Parker (Chair Of The Board & Director) $0 $0 $0
Michael Polansky (Executive Vp & Director) $0 $0 $0
Tom Van Loben Sels (Secretary/Treasurer & Director) $0 $0 $0
Tony Coles (Director) $0 $0 $0
Eric Esrailian Md Mph (Director) $0 $0 $0
Scott Gottlieb Md (Director) $0 $0 $0
Ben Horowitz (Director) $0 $0 $0
Jeff Huber (Director) $0 $0 $0
Bob Hugin (Director) $0 $0 $0
Reed Jobs (Director) $0 $0 $0
Joel Marcus (Director) $0 $0 $0
Bob Nelsen (Director) $0 $0 $0
Bruce Parker (Director) $0 $0 $0
Bob Pittman (Director) $0 $0 $0
Susan Dawson (Secretary) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2018

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$113,439,151
Expenses
$66,202,166
Net Income
$47,236,985
Net Assets
$63,915,117
Notable Sources of Revenue Percent of Total Revenue
Contributions $110,149,251
97.1%
Program Services $3,019,898
2.7%
Investment Income $270,002
0.2%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $2,200,112
3.3%
Professional Fundraising Fees $0
Other Salaries and Wages $11,876,843
17.9%
Assets/Debt
Total Assets $68,405,361
Total Liabilities $4,490,244
Net Assets $63,915,117
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Jeffrey A Bluestone (President And Ceo) $865,708 $0 $51,352
Ramy Ibrahim (Vp Clinical Research & Dev) $846,563 $0 $41,771
Ilan Zipkin (Vp Business Development) $467,913 $0 $43,289
Theresa Lavallee (Vp Translational Medicin) $405,837 $0 $56,330
Nikesh Kotecha (Vp Imformatics) $402,652 $0 $32,873
Cheryl L Selinsky Phd (Vp Research Operations) $368,172 $0 $17,472
Melinda Griffith (Chief Legal Counsel, Vp St) $349,613 $0 $29,812
Susan Schultz (Vp Business Operations) $342,513 $0 $52,205
Sean N Parker (Chair Of The Board And Dir) $0 $0 $0
Michael Polansky (Vice President & Director) $0 $0 $0
Tom Van Loben Sels (Secretary/Treasurer & Dir) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2017

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$65,939,195
Expenses
$54,685,666
Net Income
$11,253,529
Net Assets
$16,828,632
Notable Sources of Revenue Percent of Total Revenue
Contributions $63,267,590
95.9%
Program Services $2,635,842
4.0%
Investment Income $35,763
0.1%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $4,489,419
8.2%
Professional Fundraising Fees $0
Other Salaries and Wages $5,192,886
9.5%
Assets/Debt
Total Assets $17,668,982
Total Liabilities $840,350
Net Assets $16,828,632
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Jeffrey A Bluestone (President And Ceo) $774,688 $82,500 $54,162
Ramy Ibrahim (Vp Clinical Research & Dev) $740,814 $0 $29,326
Nikesh Kotecha (Vp Imformatics) $396,018 $0 $25,253
Cheryl L Selinsky Phd (Vp Research Operations) $360,438 $0 $16,847
Melinda Griffith (Chief Legal Counsel, Vp St) $359,378 $0 $41,300
Ilan Zipkin (Vp Business Development) $347,324 $0 $27,232
Susan Schultz (Vp Business Operations) $332,083 $0 $32,803
Jennifer Haslip (Vp Communications) $319,838 $0 $32,343
David Hoffman (Executive Director Intelle) $310,768 $0 $19,794
Fred Ramsdell (Vp Research) $286,594 $0 $45,736
Stephanie Liva (Sr Director Intellectual Property) $246,701 $0 $38,223
Theresa Lavallee (Vp Translational Medicin) $239,980 $0 $27,262
Irene Shin (Sr Corporate Counsel) $214,846 $0 $24,459
Hillary Nelson (Sr Director Clinical Development) $194,565 $0 $12,377
Nadine Defranoux (Program Manager Translational Science) $187,452 $0 $19,160
Sean N Parker (Chair Of The Board And Dir) $0 $0 $0
Michael Polansky (Vice President & Director) $0 $0 $0
Laurie Glimcher (Director) $0 $0 $0
Tom Van Loben Sels (Secretary/Treasurer & Dir) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2016

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$39,900,210
Expenses
$39,104,869
Net Income
$795,341
Net Assets
$5,424,603
Notable Sources of Revenue Percent of Total Revenue
Contributions $39,828,555
99.8%
Program Services $0
Investment Income $41,843
0.1%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $29,812
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $4,767,742
12.2%
Professional Fundraising Fees $0
Other Salaries and Wages $1,469,699
3.8%
Assets/Debt
Total Assets $6,100,956
Total Liabilities $676,353
Net Assets $5,424,603
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Jeffrey A Bluestone (President And Ceo) $775,000 $90,000 $134,406
Adam M Kolom (Vp Business Development) $559,000 $0 $51,084
Ramy Ibrahim (Vp Clinical Research & Dev) $547,601 $0 $111,154
Nikesh Kotecha (Vp Imformatics) $401,240 $0 $39,287
Cheryl L Selinsky Ph D (Vp Research Operations) $366,500 $0 $35,808
Melinda Griffith (Chief Legal Counsel, Vp Strategic) $357,800 $0 $42,786
David Hoffman (Executive Director Intellectual Property) $294,220 $0 $20,094
Jennifer Haslip (Vp Communications) $287,347 $0 $34,084
Susan Schultz (Vp Business Operations) $261,028 $0 $25,714
Fred Ramsdell (Vp Research) $187,526 $0 $34,691
Susanne Hildebrand Zanki (D Irector Special Projects) $184,258 $0 $17,114
Leticia Licea (Hr & Office Manager) $134,994 $0 $33,281
Ehud Gold (Executive Director Technology) $126,109 $0 $27,259
Sean N Parker (Chair Of The Board And Dir) $0 $0 $0
Michael Polansky (Vice President & Director) $0 $0 $0
Laurie Glimcher (Director) $0 $0 $0
Tom Van Loben Sels (Secretary/Treasurer & D Ir) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2015

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$73,509,764
Expenses
$69,207,119
Net Income
$4,302,645
Net Assets
$4,629,262
Notable Sources of Revenue Percent of Total Revenue
Contributions $74,021,413
> 100%
Program Services $0
Investment Income $10,489
0.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$529,183
Net Inventory Sales $0
Other Revenue $7,045
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,207,873
1.7%
Professional Fundraising Fees $0
Other Salaries and Wages $223,996
0.3%
Assets/Debt
Total Assets $5,207,689
Total Liabilities $578,427
Net Assets $4,629,262
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Jeffrey A Bluestone (President And Ceo) $612,424 $0 $51,018
Adam M Kolom (Vice President Business Development) $284,849 $0 $2,356
Michael Polansky (Vice President And Director) $0 $0 $0
Tom Van Loben Sels (Secretary/Treasurer And Director) $0 $0 $0
Sean N Parker (Chair Of The Board And Director) $0 $0 $0
Laurie Glimcher (Director) $0 $0 $0

Document Links

About This Data

Nonprofit Explorer includes summary data for nonprofit tax returns and full Form 990 documents, in both PDF and digital formats.

The summary data contains information processed by the IRS during the 2012-2019 calendar years; this generally consists of filings for the 2011-2018 fiscal years, but may include older records. This data release includes only a subset of what can be found in the full Form 990s.

In addition to the raw summary data, we link to PDFs and digital copies of full Form 990 documents wherever possible. This consists of separate releases by the IRS of Form 990 documents processed by the agency, which we update regularly.

We also link to copies of audits nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year since 2016. These audits are copied from the Federal Audit Clearinghouse.

Which Organizations Are Here?

Every organization that has been recognized as tax exempt by the IRS has to file Form 990 every year, unless they make less than $200,000 in revenue and have less than $500,000 in assets, in which case they have to file form 990-EZ. Organizations making less than $50,000 don’t have to file either form but do have to let the IRS they’re still in business via a Form 990N "e-Postcard."

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

  • Raw filing data. Includes EINs and summary financials as structured data.
  • Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
  • Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
  • Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
  • Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »